 | • レポートコード：MRC2-11QY03654 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はがんワクチンのグローバル市場について調査・分析したレポートです。種類別（予防がんワクチン、治療がんワクチン）市場規模、用途別（子宮頸がん、前立腺がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別がんワクチンの競争状況、市場シェア ・世界のがんワクチン市場：種類別市場規模 2015年-2020年（予防がんワクチン、治療がんワクチン） ・世界のがんワクチン市場：種類別市場規模予測 2021年-2026年（予防がんワクチン、治療がんワクチン） ・世界のがんワクチン市場：用途別市場規模 2015年-2020年（子宮頸がん、前立腺がん、その他） ・世界のがんワクチン市場：用途別市場規模予測 2021年-2026年（子宮頸がん、前立腺がん、その他） ・北米のがんワクチン市場分析：米国、カナダ ・ヨーロッパのがんワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのがんワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のがんワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのがんワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Glaxosmithkline、Astellas Pharma、Merck、CSL Limited、Sanpower Group、Sanofi Pasteur、Pfizer、Serum Institute of India ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Cancer is the second leading cause of morbidity and mortality worldwide. Major cause of cancer is gene mutation and rarely due to inherited genes.
Factors such as increasing number of people with cancer, rising public awareness of vaccines, presence of promising late-stage pipeline candidates, and vendors’ patient-assistance programs also augment growth in the cancer vaccines market. Dendritic cells are cells taken from a patient’s immune system and treated with chemicals before being injected back into the patient. These cells produce an enhanced immune response against the malignant cells in the body and stimulate the other cells in the immune system to fight the cancerous cells.
Market Analysis and Insights: Global Cancer Vaccines Market
The global Cancer Vaccines market size is projected to reach US$ 5471.4 million by 2026, from US$ 4755.6 million in 2020, at a CAGR of 14.3%% during 2021-2026.
Global Cancer Vaccines Scope and Market Size
Cancer Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Cancer Vaccines market is segmented into
Preventive Cancer Vaccines
Therapeutic Cancer Vaccines
Segment by Application, the Cancer Vaccines market is segmented into
Cervical Cancer
Prostate Cancer
Others
Regional and Country-level Analysis
The Cancer Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cancer Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cancer Vaccines Market Share Analysis
Cancer Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cancer Vaccines business, the date to enter into the Cancer Vaccines market, Cancer Vaccines product introduction, recent developments, etc.
The major vendors covered:
Glaxosmithkline
Astellas Pharma
Merck
CSL Limited
Sanpower Group
Sanofi Pasteur
Pfizer
Serum Institute of India
1 Study Coverage
1.1 Cancer Vaccines Product Introduction
1.2 Market Segments
1.3 Key Cancer Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cancer Vaccines Market Size Growth Rate by Type
1.4.2 Preventive Cancer Vaccines
1.4.3 Therapeutic Cancer Vaccines
1.5 Market by Application
1.5.1 Global Cancer Vaccines Market Size Growth Rate by Application
1.5.2 Cervical Cancer
1.5.3 Prostate Cancer
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cancer Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Cancer Vaccines Revenue 2015-2026
2.1.2 Global Cancer Vaccines Sales 2015-2026
2.2 Global Cancer Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Cancer Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Cancer Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Cancer Vaccines Competitor Landscape by Players
3.1 Cancer Vaccines Sales by Manufacturers
3.1.1 Cancer Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Cancer Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Cancer Vaccines Revenue by Manufacturers
3.2.1 Cancer Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Cancer Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cancer Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cancer Vaccines Revenue in 2019
3.2.5 Global Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Cancer Vaccines Price by Manufacturers
3.4 Cancer Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Cancer Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cancer Vaccines Market Size by Type (2015-2020)
4.1.1 Global Cancer Vaccines Sales by Type (2015-2020)
4.1.2 Global Cancer Vaccines Revenue by Type (2015-2020)
4.1.3 Cancer Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cancer Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Cancer Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Cancer Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Cancer Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cancer Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Cancer Vaccines Market Size by Application (2015-2020)
5.1.1 Global Cancer Vaccines Sales by Application (2015-2020)
5.1.2 Global Cancer Vaccines Revenue by Application (2015-2020)
5.1.3 Cancer Vaccines Price by Application (2015-2020)
5.2 Cancer Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Cancer Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Cancer Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Cancer Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Cancer Vaccines by Country
6.1.1 North America Cancer Vaccines Sales by Country
6.1.2 North America Cancer Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Cancer Vaccines Market Facts & Figures by Type
6.3 North America Cancer Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Cancer Vaccines by Country
7.1.1 Europe Cancer Vaccines Sales by Country
7.1.2 Europe Cancer Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cancer Vaccines Market Facts & Figures by Type
7.3 Europe Cancer Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Cancer Vaccines by Region
8.1.1 Asia Pacific Cancer Vaccines Sales by Region
8.1.2 Asia Pacific Cancer Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Cancer Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Cancer Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Cancer Vaccines by Country
9.1.1 Latin America Cancer Vaccines Sales by Country
9.1.2 Latin America Cancer Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Cancer Vaccines Market Facts & Figures by Type
9.3 Central & South America Cancer Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Cancer Vaccines by Country
10.1.1 Middle East and Africa Cancer Vaccines Sales by Country
10.1.2 Middle East and Africa Cancer Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Cancer Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Cancer Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 Glaxosmithkline
11.1.1 Glaxosmithkline Corporation Information
11.1.2 Glaxosmithkline Description and Business Overview
11.1.3 Glaxosmithkline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Glaxosmithkline Cancer Vaccines Products Offered
11.1.5 Glaxosmithkline Related Developments
11.2 Astellas Pharma
11.2.1 Astellas Pharma Corporation Information
11.2.2 Astellas Pharma Description and Business Overview
11.2.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Astellas Pharma Cancer Vaccines Products Offered
11.2.5 Astellas Pharma Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description and Business Overview
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Cancer Vaccines Products Offered
11.3.5 Merck Related Developments
11.4 CSL Limited
11.4.1 CSL Limited Corporation Information
11.4.2 CSL Limited Description and Business Overview
11.4.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020)
11.4.4 CSL Limited Cancer Vaccines Products Offered
11.4.5 CSL Limited Related Developments
11.5 Sanpower Group
11.5.1 Sanpower Group Corporation Information
11.5.2 Sanpower Group Description and Business Overview
11.5.3 Sanpower Group Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanpower Group Cancer Vaccines Products Offered
11.5.5 Sanpower Group Related Developments
11.6 Sanofi Pasteur
11.6.1 Sanofi Pasteur Corporation Information
11.6.2 Sanofi Pasteur Description and Business Overview
11.6.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi Pasteur Cancer Vaccines Products Offered
11.6.5 Sanofi Pasteur Related Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Description and Business Overview
11.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Pfizer Cancer Vaccines Products Offered
11.7.5 Pfizer Related Developments
11.8 Serum Institute of India
11.8.1 Serum Institute of India Corporation Information
11.8.2 Serum Institute of India Description and Business Overview
11.8.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Serum Institute of India Cancer Vaccines Products Offered
11.8.5 Serum Institute of India Related Developments
11.1 Glaxosmithkline
11.1.1 Glaxosmithkline Corporation Information
11.1.2 Glaxosmithkline Description and Business Overview
11.1.3 Glaxosmithkline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Glaxosmithkline Cancer Vaccines Products Offered
11.1.5 Glaxosmithkline Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Cancer Vaccines Market Estimates and Projections by Region
12.1.1 Global Cancer Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Cancer Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Cancer Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Cancer Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Cancer Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Cancer Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Cancer Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Cancer Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Cancer Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Cancer Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Cancer Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Cancer Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Cancer Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Cancer Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Cancer Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Cancer Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Cancer Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Cancer Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Cancer Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Cancer Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Cancer Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Cancer Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Cancer Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Cancer Vaccines Market Segments
Table 2. Ranking of Global Top Cancer Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Cancer Vaccines Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Preventive Cancer Vaccines
Table 5. Major Manufacturers of Therapeutic Cancer Vaccines
Table 6. Global Cancer Vaccines Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Cancer Vaccines Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Cancer Vaccines Sales by Regions 2015-2020 (K MT)
Table 9. Global Cancer Vaccines Sales Market Share by Regions (2015-2020)
Table 10. Global Cancer Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Cancer Vaccines Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Cancer Vaccines Sales Share by Manufacturers (2015-2020)
Table 13. Global Cancer Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Cancer Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Vaccines as of 2019)
Table 15. Cancer Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Cancer Vaccines Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Cancer Vaccines Price (2015-2020) (USD/MT)
Table 18. Cancer Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Cancer Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Cancer Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Cancer Vaccines Sales by Type (2015-2020) (K MT)
Table 23. Global Cancer Vaccines Sales Share by Type (2015-2020)
Table 24. Global Cancer Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Cancer Vaccines Revenue Share by Type (2015-2020)
Table 26. Cancer Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Cancer Vaccines Sales by Application (2015-2020) (K MT)
Table 28. Global Cancer Vaccines Sales Share by Application (2015-2020)
Table 29. North America Cancer Vaccines Sales by Country (2015-2020) (K MT)
Table 30. North America Cancer Vaccines Sales Market Share by Country (2015-2020)
Table 31. North America Cancer Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Cancer Vaccines Revenue Market Share by Country (2015-2020)
Table 33. North America Cancer Vaccines Sales by Type (2015-2020) (K MT)
Table 34. North America Cancer Vaccines Sales Market Share by Type (2015-2020)
Table 35. North America Cancer Vaccines Sales by Application (2015-2020) (K MT)
Table 36. North America Cancer Vaccines Sales Market Share by Application (2015-2020)
Table 37. Europe Cancer Vaccines Sales by Country (2015-2020) (K MT)
Table 38. Europe Cancer Vaccines Sales Market Share by Country (2015-2020)
Table 39. Europe Cancer Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Cancer Vaccines Revenue Market Share by Country (2015-2020)
Table 41. Europe Cancer Vaccines Sales by Type (2015-2020) (K MT)
Table 42. Europe Cancer Vaccines Sales Market Share by Type (2015-2020)
Table 43. Europe Cancer Vaccines Sales by Application (2015-2020) (K MT)
Table 44. Europe Cancer Vaccines Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Cancer Vaccines Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Cancer Vaccines Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Cancer Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Cancer Vaccines Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Cancer Vaccines Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Cancer Vaccines Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Cancer Vaccines Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Cancer Vaccines Sales Market Share by Application (2015-2020)
Table 53. Latin America Cancer Vaccines Sales by Country (2015-2020) (K MT)
Table 54. Latin America Cancer Vaccines Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Cancer Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Cancer Vaccines Revenue Market Share by Country (2015-2020)
Table 57. Latin America Cancer Vaccines Sales by Type (2015-2020) (K MT)
Table 58. Latin America Cancer Vaccines Sales Market Share by Type (2015-2020)
Table 59. Latin America Cancer Vaccines Sales by Application (2015-2020) (K MT)
Table 60. Latin America Cancer Vaccines Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Cancer Vaccines Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Cancer Vaccines Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Cancer Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Cancer Vaccines Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Cancer Vaccines Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Cancer Vaccines Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Cancer Vaccines Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Cancer Vaccines Sales Market Share by Application (2015-2020)
Table 69. Glaxosmithkline Corporation Information
Table 70. Glaxosmithkline Description and Major Businesses
Table 71. Glaxosmithkline Cancer Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Glaxosmithkline Product
Table 73. Glaxosmithkline Recent Development
Table 74. Astellas Pharma Corporation Information
Table 75. Astellas Pharma Description and Major Businesses
Table 76. Astellas Pharma Cancer Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Astellas Pharma Product
Table 78. Astellas Pharma Recent Development
Table 79. Merck Corporation Information
Table 80. Merck Description and Major Businesses
Table 81. Merck Cancer Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Merck Product
Table 83. Merck Recent Development
Table 84. CSL Limited Corporation Information
Table 85. CSL Limited Description and Major Businesses
Table 86. CSL Limited Cancer Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. CSL Limited Product
Table 88. CSL Limited Recent Development
Table 89. Sanpower Group Corporation Information
Table 90. Sanpower Group Description and Major Businesses
Table 91. Sanpower Group Cancer Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Sanpower Group Product
Table 93. Sanpower Group Recent Development
Table 94. Sanofi Pasteur Corporation Information
Table 95. Sanofi Pasteur Description and Major Businesses
Table 96. Sanofi Pasteur Cancer Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Sanofi Pasteur Product
Table 98. Sanofi Pasteur Recent Development
Table 99. Pfizer Corporation Information
Table 100. Pfizer Description and Major Businesses
Table 101. Pfizer Cancer Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Pfizer Product
Table 103. Pfizer Recent Development
Table 104. Serum Institute of India Corporation Information
Table 105. Serum Institute of India Description and Major Businesses
Table 106. Serum Institute of India Cancer Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Serum Institute of India Product
Table 108. Serum Institute of India Recent Development
Table 109. Global Cancer Vaccines Sales Forecast by Regions (2021-2026) (K MT)
Table 110. Global Cancer Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Cancer Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Cancer Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Cancer Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 114. North America: Cancer Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Cancer Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 116. Europe: Cancer Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Cancer Vaccines Sales Forecast by Region (2021-2026) (K MT)
Table 118. Asia Pacific: Cancer Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Cancer Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 120. Latin America: Cancer Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Cancer Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 122. Middle East and Africa: Cancer Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Cancer Vaccines Players
Table 127. Cancer Vaccines Customers List
Table 128. Cancer Vaccines Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Vaccines Product Picture
Figure 2. Global Cancer Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Preventive Cancer Vaccines Product Picture
Figure 4. Therapeutic Cancer Vaccines Product Picture
Figure 5. Global Cancer Vaccines Sales Market Share by Application in 2020 & 2026
Figure 6. Cervical Cancer
Figure 7. Prostate Cancer
Figure 8. Others
Figure 9. Cancer Vaccines Report Years Considered
Figure 10. Global Cancer Vaccines Market Size 2015-2026 (US$ Million)
Figure 11. Global Cancer Vaccines Sales 2015-2026 (K MT)
Figure 12. Global Cancer Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Cancer Vaccines Sales Market Share by Region (2015-2020)
Figure 14. Global Cancer Vaccines Sales Market Share by Region in 2019
Figure 15. Global Cancer Vaccines Revenue Market Share by Region (2015-2020)
Figure 16. Global Cancer Vaccines Revenue Market Share by Region in 2019
Figure 17. Global Cancer Vaccines Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Cancer Vaccines Revenue in 2019
Figure 19. Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Cancer Vaccines Sales Market Share by Type (2015-2020)
Figure 21. Global Cancer Vaccines Sales Market Share by Type in 2019
Figure 22. Global Cancer Vaccines Revenue Market Share by Type (2015-2020)
Figure 23. Global Cancer Vaccines Revenue Market Share by Type in 2019
Figure 24. Global Cancer Vaccines Market Share by Price Range (2015-2020)
Figure 25. Global Cancer Vaccines Sales Market Share by Application (2015-2020)
Figure 26. Global Cancer Vaccines Sales Market Share by Application in 2019
Figure 27. Global Cancer Vaccines Revenue Market Share by Application (2015-2020)
Figure 28. Global Cancer Vaccines Revenue Market Share by Application in 2019
Figure 29. North America Cancer Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Cancer Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Cancer Vaccines Sales Market Share by Country in 2019
Figure 32. North America Cancer Vaccines Revenue Market Share by Country in 2019
Figure 33. U.S. Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Cancer Vaccines Market Share by Type in 2019
Figure 38. North America Cancer Vaccines Market Share by Application in 2019
Figure 39. Europe Cancer Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Cancer Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Cancer Vaccines Sales Market Share by Country in 2019
Figure 42. Europe Cancer Vaccines Revenue Market Share by Country in 2019
Figure 43. Germany Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Cancer Vaccines Market Share by Type in 2019
Figure 54. Europe Cancer Vaccines Market Share by Application in 2019
Figure 55. Asia Pacific Cancer Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Cancer Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Cancer Vaccines Sales Market Share by Region in 2019
Figure 58. Asia Pacific Cancer Vaccines Revenue Market Share by Region in 2019
Figure 59. China Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Cancer Vaccines Market Share by Type in 2019
Figure 82. Asia Pacific Cancer Vaccines Market Share by Application in 2019
Figure 83. Latin America Cancer Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Cancer Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Cancer Vaccines Sales Market Share by Country in 2019
Figure 86. Latin America Cancer Vaccines Revenue Market Share by Country in 2019
Figure 87. Mexico Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Cancer Vaccines Market Share by Type in 2019
Figure 94. Latin America Cancer Vaccines Market Share by Application in 2019
Figure 95. Middle East and Africa Cancer Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Cancer Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Cancer Vaccines Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Cancer Vaccines Revenue Market Share by Country in 2019
Figure 99. Turkey Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Cancer Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Cancer Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Cancer Vaccines Market Share by Type in 2019
Figure 106. Middle East and Africa Cancer Vaccines Market Share by Application in 2019
Figure 107. North America Cancer Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Cancer Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Cancer Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Cancer Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Cancer Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Cancer Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Cancer Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Cancer Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Cancer Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Cancer Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
がんワクチン薬剤用パイプラインの世界市場（～2026年） Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. Germany, the U.S. and Japan represent the largest markets for cancer vaccine manufacturers. Market Analysis and Insights: Global Cancer Vaccines Drug Pipeline Mark…- mRNA癌ワクチン・治療薬の世界市場（～2026年） mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically wh…
- 前立腺がんの世界市場（～2026年） Prostate cancer is cancer that occurs in the prostate. Market Analysis and Insights: Global Prostate Cancer Market The global Prostate Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prostate Cancer Scope and Ma…
- ホルモン抵抗性前立腺がんの世界市場（～2026年） Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …
- 子宮頸がんスクリーニングの世界市場（～2026年） Cervical screening is the process of recognizing and expelling abnormal tissue or cells in the cervix before precancerous cervical lesions or cervical malignancy develops. Continuous growth of cancer‘s impact on Public Health is the primary factor that drives the Cervical Cancer Screening Market. Th…